Synthetic Biology

SynBio〉 In Research〉 The Clinic〉 To Improving Patient Outcomes 

Stay tuned to THE top developments in synthetic biology within translational research, the clinic and in medicine.

Read more in our editorial

SMS Alarms

Synthetic Biology

SynBio〉 In Research〉 The Clinic〉 To Improving Patient Outcomes 

Stay tuned to THE top developments in synthetic biology within translational research, the clinic and in medicine.

Read more in our editorial

Latest News

The Synthetic Genome

prinme editing to correct genetic liver disease

In vivo prime editing for metabolic liver disease treatment

Date: 21st March 2022

fluoPEER optimising prime editing

PEER enrichment for prime editing

Date: 4th March 2022

gene replacement therapy for thalassemia

Thalassemia gene therapy drives transfusion independence in children

Date: 24th February 2022

CRISPR platform for T cell regulation

Novel CRISPR platform to decode the immune system

Date: 11th February 2022

genetically modified pig kidney transplanted into human

World’s first clinical-grade transplant of gene edited pig kidneys into humans

Date: 28th January 2022

pug heart transplanted into humans

World’s first genetically modified pig heart transplanted into adult human

Date: 11th January 2022

Load more

The Synthetic Proteome

spider silk fusion with p53 to fight cancer

Spinning stability into cancer drugs with spider silk

Date: 17th March 2022

delivery of proteins for genetic disease

Accelerating base editing protein therapy for genetic diseases

Date: 19th January 2022

new protein therapy glaucoma

New protein therapy for severe paediatric glaucoma

Date: 21st October 2021

synthetic muscle fibres stronger than Kevlar

Microbes build synthetic muscle fibres stronger than Kevlar

Date: 1st September 2021

antibody therapy for congenital disease

First targeted antibody therapy to counter lethal congenital disease

Date: 25th June 2021

Nasal hybrid antibodies protect against COVID-19

New hybrid antibody to fight COVID-19 to be delivered by nasal spray

Date: 10th June 2021

Load more

Synthetic Cells, Tissues and Beyond

Listeria delivers tetanus to cold tumours

Killing pancreatic cancer with tetanus-loaded Listeria

Date: 31st March 2022

molecular stealth cloak for therapeutic bacteria

Killing cancer with an engineered stealth cloak for microbes

Date: 25th March 2022

cyokine factory implants eliminates cancer

Implantable cytokine drug factories eliminate cancer in days

Date: 8th March 2022

creating universal organs for transplant

Engineering universal donor transplant organs

Date: 22nd February 2022

biohybrid fish

Biohybrid fish is a swim towards building an artificial heart

Date: 17th February 2022

brain organoids for autism research

Brain organoids unravel the mystery of autism risk genes on pathology

Date: 7th February 2022

Load more

Business/World

cellular therapy to improve symptoms of duchenne muscular dystrophy

Cellular therapy is first to improve late-stage symptoms of Duchenne

Date: 15th March 2022

gene replacement therapy for thalassemia

Thalassemia gene therapy drives transfusion independence in children

Date: 24th February 2022

mRNA therapy eradicates tumours

mRNA cytokine therapy eradicates tumours and enters clinical trials

Date: 10th September 2021

Launch of Prime Medicine

Pioneering Prime Medicine launch with $315 million in financing

Date: 15th July 2021

immunotherapy for Alzheimer's disease

Immunotherapy for Alzheimer’s disease reduces tau pathology

Date: 18th May 2021

Ginkgo Bioworks goes public in $17.5B deal

The organism company Ginkgo Bioworks goes public in $17.5B deal

Date: 13th May 2021

Load more

Articles/Interviews

new target to treat Alzheimer's disease

New major pathogenic target found for treating Alzheimer’s

Date: 10th March 2022

BioTechScope’s top synthetic biology articles of 2021

Date: 21st December 2021

cancer cells drives drug sensitivity

Cancer cell state & modulation opens new frontiers for drug responses

Date: 17th December 2021

new approach for ovarian immunotherapy resistant cancer

New therapeutic approach increases effectiveness of ovarian cancer immunotherapy

Date: 23rd November 2021

glia therapies to treat necrotising enterocolitis

New targets to treat necrotising enterocolitis in premature infants

Date: 30th September 2021

chemical shield for immunotherapy

Stimuli-responsive shield activates immunotherapy in tumours

Date: 14th September 2021

Load more

Companies Working in Synthetic Biology

Our interactive map showcases companies working in this technology area.

View map

Technology Areas

About us

Legal Notices

BioTechScope

Founded in 2019, Oxfordshire, United Kingdom

E:

© BioTechScope Ltd. All rights reserved